3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
3
Fallopian Tube Neoplasms
2
Ovarian Cancer Recurrent
1
Interventions
zanidatamab
1
tislelizumab
1
sitravatinib
1
pamiparib
1
lenvatinib
1
Temozolomide
1
Midazolam
1
HMPL-013
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Malignancies
×
1-dodecylpyridoxal
×
30 days
×
Clear all
No trials found.